These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6017979)

  • 1. Fibrinogen from human plasma: preparation by precipitation with heavy-metal coordination complex.
    Brown ME; Rothstein F
    Science; 1967 Feb; 155(3765):1017-9. PubMed ID: 6017979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological studies of coagulation factor XIII.
    Israels ED; Paraskevas F; Israels LG
    J Clin Invest; 1973 Oct; 52(10):2398-403. PubMed ID: 4199604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of fibrinogen in normal human plasma in the presence and absence of anticoagulants.
    Roberts PS; Regelson W; Kingsbury B
    J Lab Clin Med; 1973 Nov; 82(5):822-8. PubMed ID: 4746821
    [No Abstract]   [Full Text] [Related]  

  • 4. VARIABILITY OF THE ANTICOAGULANT FRACTION OF INCUBATED FIBRINOGEN.
    TRIANTAPHYLLOPOULOS E; TRIANTAPHYLLOPOULOS DC
    Am J Physiol; 1965 Mar; 208():521-7. PubMed ID: 14264744
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the terminal degradation products of canine fibrinogen by plasmin.
    Chen JP; Hutchison HT; Nanninga LB; Guest MM
    Biochim Biophys Acta; 1975 Mar; 386(1):69-79. PubMed ID: 123781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isolation of fibrinogen with mercury complexes and their interaction.
    Mannuzza FJ; Rothstein F
    Vox Sang; 1971 May; 20(5):480. PubMed ID: 5099019
    [No Abstract]   [Full Text] [Related]  

  • 8. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the heat precipitation method for plasma fibrinogen estimation.
    Millar HR; Simpson JG; Stalker AL
    J Clin Pathol; 1971 Dec; 24(9):827-30. PubMed ID: 5003786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
    Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
    J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Normal values of hemoglobin, hematocrit, blood coagulation factors, and fibrinolysis in New Zealand white rabbits].
    Marval E; García L; Candela DE; Arocha-Piñango CL
    Sangre (Barc); 1992 Oct; 37(5):355-61. PubMed ID: 1293775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital dysfibrinogenemia: fibrinogen Detroit.
    Mammen EF; Prasad AS; Barnhart MI; Au CC
    J Clin Invest; 1969 Feb; 48(2):235-49. PubMed ID: 4974308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual A alpha 16Arg-->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings.
    Galanakis D; Spitzer S; Scharrer I
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):67-71. PubMed ID: 8457654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION.
    KANTOR FS
    J Exp Med; 1965 May; 121(5):849-59. PubMed ID: 14278234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 17. The chemistry of blood coagulation.
    Baugh RF; Hougie C
    Clin Haematol; 1979 Feb; 8(1):3-30. PubMed ID: 367664
    [No Abstract]   [Full Text] [Related]  

  • 18. The specificity of the fibrinogen-thrombin reaction.
    Hogg DH; Blombäck B
    Thromb Res; 1974 Nov; 5(5):685-93. PubMed ID: 4445989
    [No Abstract]   [Full Text] [Related]  

  • 19. A method for the measurement of fibrinolytic activity based on one dimensional diffusion using small glass tubes. II. With special reference to the differences between the use of plasminogen-rich fibrinogen and that of plasminogen-free fibrinogen as the substrates.
    Yasukouchi T; Fujine M; Kohn S; Sakurama S; Morioka T
    Thromb Haemost; 1977 Jun; 37(3):456-63. PubMed ID: 578026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ability of bovine fibrinogen to accept and retain plasminogen proactivator specific for human blood].
    Belitser VA; Varetskaia TV; Tsariuk LA
    Ukr Biokhim Zh; 1976; 48(6):721-6. PubMed ID: 1034991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.